$Identification of Anti-HLA-C Autoantibody As Risk Factor for Primary Platelet Transfusion Refractoriness in Patients with Hematologic Disorders$

Identification of Anti-HLA-C Autoantibody As Risk Factor for Primary Platelet Transfusion Refractoriness in Patients with Hematologic Disorders

Platelet transfusion is an important supporting treatment for hematologic disorders, especially in bone marrow failure disease and post-chemotherapy myelosuppression. However, in patients experienced multiple transfusions, platelet transfusion refractoriness (PTR) occasionally happened. Up to date,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.4035-4035
Hauptverfasser:	Li, Xunhua, Hu, Tonglin, Liu, Qi, Dong, Jingjie, Guo, Junfeng, Hong, Yaonan, Shen, Yingying, Shen, Yiping, Shen, Jianping, Zhou, Yuhong, Ye, Baodong, Wu, Dijiong
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!